Thumbnail
Access Restriction
Open

Author Hartnoll, R. L.
Source CiteSeerX
Content type Text
File Format PDF
Subject Domain (in DDC) Computer science, information & general works ♦ Data processing & computer science
Subject Keyword Drug Epidemiology ♦ Key Indicator ♦ Member State ♦ European Institution ♦ Historical Background ♦ Bull Narc ♦ European Level ♦ Pompidou Group ♦ Core Data ♦ European Union Epidemiological Information System ♦ Policy Need ♦ Present Article ♦ Context Information ♦ European Monitoring Centre ♦ Drug Addiction ♦ Information Need ♦ Drug Indica-tors ♦ Epidemiological Indicator ♦ Health Consequence ♦ Policy Maker ♦ Action Plan ♦ Key Epidemiological Indicator ♦ European Union ♦ European Council ♦ European Union Drug Strategy ♦ Quantitative Research ♦ Expert Epidemiology Group ♦ Drug Phenomenon ♦ Institutional Instrument ♦ Drug Phe-nomenon ♦ Drug Prevalence ♦ Wider International Development
Abstract The present article traces the evolution of drug epidemiology in Europe from the 1960s to the present within the context of changing perceptions of the drug phe-nomenon and changing information needs of policy makers. In particular, it focuses on how epidemiological indicators developed as part of emerging European political and institutional instruments and structures for responding to illegal drugs. It also notes the importance of wider international developments in drug epidemiology and of cooperation between networks of researchers. Interest in epidemiology at the European level was first observed in the early 1970s with the creation of the Pompidou Group. Work on a variety of drug indica-tors accelerated in the 1980s following the establishment of an expert epidemiology group within the Pompidou Group of the Council of Europe. This foreshadowed the founding by the European Union of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in 1993. During the 1990s, EMCDDA, together with the member States, further devel-oped five key epidemiological indicators of drug prevalence and health consequences in order to improve the quality and comparability of core data needed to describe and analyse the drug phenomenon at the European level. In the early 2000s, those indi-cators were adopted by member States, endorsed by the European Council and incor-porated into the European Union Drugs Strategy and Action Plan 2000-2004. The goal is now to ensure implementation of those key indicators in member States as the basis for a European Union epidemiological information system on drugs. It is essen-tial that the indicators are complemented by qualitative and quantitative research and context information in order to interpret the data correctly and provide answers that are relevant to policy needs.
Educational Role Student ♦ Teacher
Age Range above 22 year
Educational Use Research
Education Level UG and PG ♦ Career/Technical Study
Learning Resource Type Article